Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 10;7(4):e2016.
doi: 10.1002/hsr2.2016. eCollection 2024 Apr.

A mini review of reinfection with the SARS-CoV-2 Omicron variant

Hongwei Shen  1 , Dingqiang Chen  2 , Chenglin Li  1 , Tingting Huang  1 , Wen Ma  1
Affiliations

A mini review of reinfection with the SARS-CoV-2 Omicron variant

Hongwei Shen et al. Health Sci Rep. .

Abstract

Background: COVID-19 has caused severe morbidity and mortality worldwide. After the end of the dynamic zero-COVID policy in China in December, 2022, concerns regarding reinfection were raised while little was known due to the lack of surveillance data in this country.

Aims: This study reviews the probability, risk factors, and severity of severe acute respiratory syndrome coronavirus 2 Omicron variant reinfection, as well as the interval between infections, risk of onward transmission by reinfected cases, and the role of booster vaccination against reinfection.

Sources: References for this review were identified through searches of PubMed and Web of Science up to September 24, 2023.

Results: The rate of reinfection ranges from 3.1% to 13.0%. Factors associated with a higher risk of reinfection include being female, having comorbidities, and being unvaccinated. Reinfection with the BA.4 or BA.5 variant occurs approximately 180 days after the initial infection. Reinfections are less clinically severe than primary infections, and there is evidence of lower transmissibility. The debate surrounding the effectiveness and feasibility of booster vaccinations in preventing reinfection continues.

Conclusions: The reinfection rate during the Omicron epidemic is significantly higher than in previous epidemic periods. However, the symptoms and infectivity of reinfection were weaker than those of the prior infection. Medical staff and individuals at high risk of reinfection should be vigilant. The efficacy of booster vaccinations in reducing reinfection is currently under debate.

Keywords: COVID‐19; Omicron variant; SARS‐CoV‐2; infectiousness; interval; reinfection; severity; wane of immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐733. - PMC - PubMed
    1. Han X, Li X, Zhu B, et al. Effect of lockdown and mass testing for the SARS‐CoV‐2 omicron epidemic on reducing new infections in shenzhen, China. Healthcare. 2022;10(9):1725. - PMC - PubMed
    1. Lau H, Khosrawipour V, Kocbach P, et al. The positive impact of lockdown in Wuhan on containing the COVID‐19 outbreak in China. J Travel Med. 2020;27(3):taaa037. - PMC - PubMed
    1. Zhu S, Feng S, Ning X, Zhou Y. Analysis of China's fight against COVID‐19 from the perspective of policy tools—policy capacity. Front Public Health. 2022;10:951941. - PMC - PubMed
    1. Yang H, Nie H, Zhou D, Wang Y, Zuo W. The effect of strict lockdown on omicron SARS‐CoV‐2 variant transmission in shanghai. Vaccines (Basel). 2022;10(9):1392. - PMC - PubMed

LinkOut - more resources